Cite
MLA Citation
Marc S Raab et al.. “MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial.” Lancet, vol. 7, no. 5, 2020, pp. e381–e394. http://access.bl.uk/ark:/81055/vdc_100104133546.0x000006